Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,890
Total Claims
$881K
Drug Cost
792
Beneficiaries
$1,112
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+45%
Opioid rate vs peers
3.8% vs 2.6% avg
+4%
Cost per patient vs peers
$1,112 vs $1,068 avg
-2%
Brand preference vs peers
8.8% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
3.8%
Opioid Rate
371
Opioid Claims
$5,526
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 866 claims · $716K
Generic: 8,992 claims · $161K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Tasimelteon | 14 | $345K |
| Apixaban | 70 | $73K |
| Semaglutide | 45 | $51K |
| Dulaglutide | 17 | $30K |
| Rivaroxaban | 15 | $19K |
| Budesonide/Formoterol Fumarate | 27 | $16K |
| Fluticasone/Umeclidin/Vilanter | 16 | $13K |
| Mirabegron | 23 | $13K |
| Fluticasone/Vilanterol | 20 | $12K |
| Varicella-Zoster Ge/As01b/Pf | 45 | $8,911 |
| Levothyroxine Sodium | 543 | $7,996 |
| Levothyroxine Sodium | 67 | $7,303 |
| Albuterol Sulfate | 162 | $6,547 |
| Atorvastatin Calcium | 426 | $5,908 |
| Losartan Potassium | 367 | $4,788 |
Prescribing Profile
Patient Profile
73
Avg Age
68%
Female
1.08
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About